Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Internal Medicine (Tokyo, Japan)|May 29, 2024
Pulmonary Tumor Embolism due to Oropharyngeal Carcinoma Diagnosed by a Transbronchial Lung BiopsyMoriyasu Anai, Shohei Hamada, Takayuki Jodai, et al.Respirology Case Reports|December 21, 2022
Successful treatment with dupilumab for mucus plugs in severe asthmaMoriyasu Anai, Chieko Yoshida, Hiroki Izumi, et al.Thoracic Cancer|December 9, 2022
Primary lung sebaceous carcinoma successfully treated with radiotherapy and pembrolizumab: A case reportYasumiko Jodai, Shohei Hamada, Mikiko Yamada, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 29, 2018
Lung abscess following bronchoscopy due to multidrug-resistant Capnocytophaga sputigena adjacent to lung cancer with high PD-L1 expressionYohei Migiyama, Moriyasu Anai, Kosuke Kashiwabara, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 1, 2026
The Impact of Treatable Traits on Clinical Remission in Patients with AsthmaChieko Yoshida, Kei Muramoto, Moriyasu Anai, et al.International Journal of Clinical Oncology|February 22, 2022
Clinical impact of cerebral infarction in patients with non-small cell lung cancerMoriyasu Anai, Koichi Saruwatari, Tokunori Ikeda, et al.Respiratory Investigation|September 24, 2024
Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancerMoriyasu Anai, Hiroki Inoue, Koichi Saruwatari, et al.Journal of Thoracic Disease|March 20, 2024
Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutationMoriyasu Anai, Koichi Saruwatari, Kosuke Imamura, et al.Cureus|July 24, 2026
A Case Report of Non-toxigenic Corynebacterium belfantii With Suspected Diphtheria InfectionKaori Tsumori, Chie Shitada, Tomohiro Ikeda, et al.Oncoimmunology|June 3, 2022
Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitorsYusuke Tomita, Yoshihiko Goto, Shinya Sakata, et al.Pageof 2